<i>Ramulus Mori</i> (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
Nonalcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes mellitus (T2DM) have highly related mechanisms. <i>Ramulus Mori</i> (Sangzhi) alkaloids (SZ-A) from <i>Morus alba</i> L. were approved in 2020 for the treatment of T2DM. In this study, we examined the ther...
Main Authors: | Yan-Min Chen, Chun-Fang Lian, Qian-Wen Sun, Ting-Ting Wang, Yuan-Yuan Liu, Jun Ye, Li-Li Gao, Yan-Fang Yang, Shuai-Nan Liu, Zhu-Fang Shen, Yu-Ling Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/11/5/905 |
Similar Items
-
Pharmacokinetics and tissue distribution of Ramulus Mori (Sangzhi) alkaloids in rats and its effects on liver enzyme activity
by: Zhihua Liu, et al.
Published: (2023-02-01) -
Ramulus mori (Sangzhi) alkaloids regulates gut microbiota disorder and its metabolism profiles in obese mice induced by a high-fat diet
by: Dongdong Liu, et al.
Published: (2023-03-01) -
Ramulus Mori (Sangzhi) alkaloids ameliorate high-fat diet induced obesity in rats by modulating gut microbiota and bile acid metabolism
by: Xin Shang, et al.
Published: (2024-12-01) -
Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
by: Quan Liu, et al.
Published: (2021-04-01) -
Preparation of Polysaccharides from <i>Ramulus mori</i>, and Their Antioxidant, Anti-Inflammatory and Antibacterial Activities
by: Wansha Yu, et al.
Published: (2019-02-01)